Calvert Equity Fund
Calvert Social Investment Fund · 4 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Calvert Equity Fund is an actively managed U.S. equity fund. 6% of CSIEX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 94% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q1
The Funds investment objective is to seek growth of capital through investment in stocks believed to offer opportunities for potential capital appreciation.
The fund invests in common stocks of large-cap U.S. companies selected for high quality—demonstrated by strong balance sheets, sustainable cash flow, and consistent long-term earnings growth—that trade below intrinsic value, with up to 25% in foreign securities traded on U.S. exchanges. Environmental, social, and governance analysis from Calvert Research and Management informs security selection to identify companies that manage ESG risks adequately. The fund constructs a diversified portfolio and may sell holdings when fundamentals deteriorate or valuations become unattractive.
| Share class | Expense ratio |
|---|---|
| CSIEX | 0.91% |
| CSECX | 1.66% |
| CEYIX | 0.66% |
| CEYRX | 0.59% |
Portfolio turnover 14.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.51% |
| Cash & short-term | 1.52% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Health Care | 24.4% |
| Financials | 21.5% |
| Industrials | 13.8% |
| Information Technology | 12.2% |
| 8 smaller | 28.1% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Exited: ARBORVIEW CAPITAL PARTENERS LP, BRIDGES VENTURES U.S SUSTAINAB, NEW MARKETS EDUCATION PRTNR LP
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +0.56% | +20.73% | +23.72% | 9.50% | -9.74% | |
| -0.20% | +18.07% | +19.19% | 9.48% | -9.95% | |
| +0.83% | +21.67% | +25.32% | 9.49% | -9.65% | |
| +0.88% | +21.91% | +25.69% | 9.52% | -9.66% |
These classes hold the same portfolio, so the 6.50pp spread over 5 years is the cost difference between them — roughly 1.30pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| V | Visa IncV | 5.01% | $343.09 | $167.84M | 489.2K |
| MA | Mastercard IncMA | 4.99% | $513.60 | $167.19M | 325.5K |
| TMO | Thermo Fisher Scientific IncTMO | 4.73% | $501.36 | $158.42M | 316.0K |
| DHR | Danaher CorpDHR | 4.69% | $190.48 | $157.09M | 824.7K |
| VRSK | Verisk Analytics IncVRSK | 4.33% | $179.53 | $145.09M | 808.1K |
| GOOG | Alphabet IncGOOG | 4.25% | $353.33 | $142.23M | 402.5K |
| TJX | The TJX Cos IncTJX | 4.16% | $151.50 | $139.49M | 920.7K |
| VRSN | VeriSign IncVRSN | 4.13% | $251.56 | $138.47M | 550.4K |
| A | Agilent Technologies IncA | 3.90% | $132.83 | $130.63M | 983.4K |
| MSFT | Microsoft CorpMSFT | 3.73% | $373.02 | $124.80M | 334.6K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 43.92% of net assets, top 25 80.69%, across 64 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free